
Mission Bio Secures Equity Funding to Advance Tapestri Tri-Omics Platform for Precision Medicine
Mission Bio, a South San Francisco-based leader in single-cell multi-omics, announced, the successful completion of an equity financing round led by Ally Bridge Group, with participation from existing investors including Novo Holdings, Mayfield, Cota Capital, and Agilent Technologies. The undisclosed…